2-Nitro-1-phenyl-1-propanol (NPP) is a nitro alcohol with vasodilator activity in the rat aorta. The present study investigated the vasodilator properties of NPP in small vessels of the mesenteric bed, which, contrary to the aorta, contains resistance vessels. Using myography, isometric contractions were recorded in rings of secondand third-order branches from the rat mesenteric artery. NPP relaxed mesenteric ring preparations that were contracted with phenylephrine, U-46619, and KCl (40 mM -free conditions, NPP did not alter transient contractions that were evoked by caffeine, but it reduced transient contractions that were evoked by phenylephrine. In mesenteric rings that were loaded with the fluorescent Ca 2+ indicator Fluo-4 AM and stimulated with phenylephrine, NPP blunted both contractions and fluorescence signals that were related to cytosolic Ca 2+ levels. In conclusion, the vasodilatory actions NPP on mesenteric vessel resistance involved the participation of cyclic nucleotides and the opening of K + channels.
Introduction
The nitro alcohol 2-nitro-1-phenyl-1-propanol (NPP; CAS no. 6343-57-3) is structurally close to norephedrine, a sympathomimetic agonist that is useful as an upper respiratory decongestant (Bravo, 1988; Meltzer et al., 2010) . Chemically, they differ from one another because NPP possesses a NO 2 functional group, whereas norephedrine contains a NH 2 group. Such substituents likely determine the pharmacological profile of these compounds. Despite the well-known vasoconstrictor properties of norephedrine (Persson et al., 1973) , NPP has been shown to exert vasodilator effects in isolated rat aorta (Brito et al., 2016) , but it unlikely acts as an adrenergic ligand.
As reported in aortic smooth muscle (Brito et al., 2016) , the induction of vasodilation by NPP appears to occur through the stimulation of guanylate cyclase, which augments the intracellular levels of cyclic guanosine monophosphate (cGMP) . Cellular responses to cGMP involve target proteins, known as cGMP-dependent protein kinases (e.g., protein kinase G [PKG]; Lucas et al., 2000) . Once activated, targeted proteins may induce other events that result in lower Ca 2+ release from intracellular stores (Xia et al., 2001) or higher Ca 2+ sequestration to the sarcoplasmic reticulum (Koller et al., 2003) .
Vasorelaxant compounds that stimulate guanylate cyclase can also modulate the gating of K + channels, resulting in pronounced hyperpolarization and the inhibition of force in vascular smooth muscle (Kubo et al., 1994) . In the rat mesenteric artery, several types of K + channels appear to mediate vasorelaxant actions that are induced by the release of endothelium-derived hyperpolarizing factor (EDHF; Hilgers et al., 2006) . Endothelium-derived mechanisms that are involved in muscle tone regulation in small vessels differ from conduit vasculature in several aspects. For example, nitric oxide (NO) is the predominant factor in large conduit vessels, whereas EDHF appears to contribute more significantly as the vessel size decreases (Clark and Fuchs, 1997; Hilgers et al., 2006; Shimokawa et al., 1996) . The vasodilator effects of NPP on the rat aorta suffered no change under blockade of K + channels with tetraethylammonium, despite the higher levels of cGMP. Additionally, its relaxant effects decreased weakly in the presence of an adenylate cyclase inhibitor (Brito et al., 2016) . In the present study, we evaluated whether NPP interferes with cellular events that are related to the guanylate cyclase-K + channel pathway to produce vasodilator effects in small arteries of the rat mesenteric bed.
Materials and methods

Animals
Male Wistar rats (220-280 g) were obtained from the institutional facilities of the Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil. The rats were housed under standard conditions with free access to food and water. All of the animals were handled in accordance with the Ethical Principles for the Care and Use of Laboratory Animals, published by the Brazilian National Council for Animal Experimentation (RN12/2013), and with approval from the institutional animal Ethics Committee (no. 22/ 2014).
Solutions and drugs
We used modified Krebs-Henseleit solution (MKHS; 118.0 mM NaCl, 4.7 mM KCl, 1.18 mM KH 2 PO 4 , 1.18 mM MgSO 4 ·7H 2 O, 2.5 mM CaCl 2 , 25.0 mM NaHCO 3 , and 11.0 mM glucose) as the physiological medium to maintain the viability of isolated tissues. Salts that were used to prepare MKHS were obtained from Merck (Darmstadt, Germany) and Vetec (Rio de Janeiro, Brazil). For the experiments under Ca 2+ -free conditions, CaCl 2 was omitted from the normal MKHS, and ethylene glycol-bis(b-aminoethyl ether)N,N,N′,N′-tetraacetic acid (EGTA; 1 mM) was added. NPP was purchased from Sigma (St. Louis, MO, USA), dissolved directly in MKHS at 2 mM, and sonicated just before use. To induce sustained contractions in isolated preparations of mesenteric vessels, we used either phenylephrine, depolarizing MKHS that contained high KCl concentrations, or the thromboxane A 2 analogue U-46619 as a contractile stimulus. Some of the experiments with NPP were conducted with vascular preparations that were pretreated (10-20 min before applying the contractile stimulus) with the K + channel inhibitors tetraethylammonium, glibenclamide, 4-aminopyridine (4-AP), BaCl 2 , CsCl, and apamin, the nitric oxide synthase inhibitor L-NG-nitroarginine methyl ester (L-NAME), the cyclooxygenase inhibitor indomethacin, the adenylate cyclase inhibitor cis-N-(2-phenylcyclopentyl)-azacyclotridec- 
Contractility of isolated mesenteric vessels
The rats were euthanized under 2,2,2-tribromoethanol anesthesia (250 mg/kg, i.p.). The mesenteric vascular bed was removed and placed in MKHS at room temperature. Second-or third-order branches of the mesenteric artery (approximately 2 mm long segments) were mounted in a 610M-DMT Wire Myograph System (Danish Myo Technology, Aarhus, Denmark) by two tungsten wires (outer diameter 40 µm; approximately 2 cm length). The wires passed through the lumen of each ring, one fixed to a micrometer for length adjustments and the other connected to a force transducer according to the method described by Mulvany and Halpern (1977) . The organ bath contained warmed (37°C) MKHS that was continuously bubbled with 5% CO 2 in O 2 . After a 30 min equilibration period, the segments were stretched to their optimal lumen diameter for active tension development. The optimal lumen diameter was determined based on the internal circumference/wall tension ratio for each segment by setting the internal circumference, L 0 , to 90% of what the vessels would have if they were exposed to a passive tension that is equivalent to the tension produced by transmural pressure of 100 mmHg (Mulvany and Halpern, 1977) . This procedure was performed using specific software for the normalization of resistance arteries (DMT Normalization Module, AD Instruments, Bella Vista, Australia). For endothelium denudation, a human hair was inserted into the lumen of the arteries, and friction movements were made against the arterial wall. The lack of endothelial functionality was pharmacologically confirmed by the absence of relaxation after the addition of acetylcholine (1 µM) on the plateau of a K + (60 mM)-induced contraction.
Simultaneous measurement of tension and intracellular Ca
2+ concentration in rings of mesenteric vessels
Vessel segments from the second-order branch of the superior mesenteric artery were dissected and maintained in oxygenated MKHS at room temperature. After removing adherent fat under a microscope, cylindrical ring-like segments were obtained and carefully mounted as previously described for the experiments that used the Wire Myograph System. To measure the levels of intracellular Ca 2+ , a confocal myograph (DMT120CW Confocal Wire Myograph, Aarhus, Denmark) allowed the capturing of high-resolution images using fluorescent markers.
Under constant temperature (37°C), a resting tension of 11.5 kPa was applied to each isolated artery segment. The preparation was incubated for 30 min in the absence of light with the fluorescent Ca 2+ indicator Fluo-4 AM (5 μM) that was supplemented with pluronic acid (0.1%, v/v; Life Technologies, Carlsbad, CA, USA). After washing to remove the extracellular dye, Ca 2+ fluorescence was detected with an inverted confocal microscope (Olympus, IX81) at 20× magnification and excitation/emission wavelengths of 488/505-515 nm. The sampling rate was 1 frame/2.5 s. Intracellular Ca 2+ variations are expressed as the ratio F/F 0 , where F is the intensity of fluorescence that was recorded during the course of the experiment, and F 0 is the intensity of fluorescence at the start of the experiment. Simultaneously, variations in tension were recorded with an isometric force transducer that was connected to a data acquisition system (PowerLab 8/30, AD Instruments).
Statistical analysis
The data are expressed as mean ± the standard error of the mean (S.E.M.), and n indicates the number of experiments. The EC 50 (i.e., the concentration of NPP at which 50% of a contractile response was inhibited) values were calculated by interpolation from semi-logarithmic plots and are expressed as geometric means [95% confidence interval]. Statistical significance (P < 0.05) was assessed using the Mann-Whitney U-test and one-or two-way analysis of variance (ANOVA), followed by the Holm-Sidak post hoc test when appropriate.
Results
Vasorelaxant effects of NPP on rat isolated mesenteric vessels
Endothelium-intact mesenteric artery rings that were incubated in Ca 2+ -containing medium were initially precontracted with either 10 µM phenylephrine (n=7; corresponding to 16.0 ± 1.8 mN) or 1 µM U-46619 (n==7; 11.8 ± 1.4 mN). NPP (0.01-10 µM) was added during the steady-state contraction and fully relaxed the preparations in a concentration-dependent manner (P < 0.001, one-way ANOVA; -containing medium (Fig. 1B) . The magnitude of such a transient response was unaffected by 30 μM NPP (n=5) but was significantly reduced by 100 μM NPP (n=5; P < 0.05, ANOVA and Holm Sidak-test), a concentration that did not change transient contractions that were induced by 20 mM caffeine in Ca 2+ -free medium (Fig. 1C). 3.3. Inhibitory effects of NPP on phenylephrine-induced contractions occurred simultaneously with a decrease in cytosolic levels of Ca
2+
In Fluo-4 AM-loaded mesenteric preparations, 10 µM phenylephrine (n=5) induced simultaneous and rapid increases in the intracellular concentration of Ca 2+ and the contractile tonus ( Fig. 2A) . Pretreatment for 10 min with 30 μM (n=5; Fig. 2B ) and 100 µM (n=3; Fig. 2C ) NPP significantly decreased (P < 0.05, Holm-Sidak test) the fluorescence ratio (F/F 0 ) related to the levels of cytoplasmic Ca 2+ to 53.64% ± 11.30% and 8.10% ± 2.40% of control fluorescence, respectively (Fig. 2D ). The contractile force that was induced by phenylephrine was significantly decreased to 63.85% ± 10.10% and 2.94% ± 0.84% in the presence of 30 and 100 µM NPP, respectively (P < 0.05, HolmSidak test; Fig. 2E ).
Vasodilator effects of NPP are not determined by the integrity of the endothelial layer
Removal of the vascular endothelium (n=6) or the pretreatment of endothelium-intact mesenteric artery rings with 3 µM indomethacin (n=5) or 100 µM L-NAME (n=8) did not change the vasorelaxant effects of NPP in preparations that were contracted by 1 µM U-46619 (Fig. 3A) . In contrast, the vasorelaxant effects that were induced by NPP were significantly decreased (P < 0.05, two-way ANOVA; In endothelium-intact mesenteric rings that were contracted by 0.5 μM U-46619 in the concomitant presence of 100 μM L-NAME and 10 μM indomethacin, the addition of 30 µM acetylcholine relaxed 40.84% ± 3.90% of the contraction (n=6; Fig. 3C ). This relaxant effect of acetylcholine significantly decreased (P < 0.001, Holm-Sidak test) to 1.80% ± 2.76% [n=4] of the magnitude of the contraction induced by U-46619 in the presence of 0.5 µM apamin. In the simultaneous presence of L-NAME and indomethacin, 1 µM NPP relaxed 96.58% ± 0.87% (n=5) of the U-46619-induced contraction. The concomitant presence of L-NAME, indomethacin, and apamin NPP relaxed 82.80% ± 1.90% of the contraction (n=6), a value that was significantly lower than that observed in the absence of apamin (P < 0.001, Holm-Sidak test).
Pharmacological blockade of K + channels decreased the vasorelaxant effects of NPP
The pretreatment of mesenteric preparations with 200 µM 4-AP (n=5) and 1 µM glibenclamide (n=5) did not alter the vasorelaxant effect of NPP in preparations that were contracted by phenylephrine (10 µM; Fig. 4A ). In contrast, the ability to relax phenylephrineinduced contractions was significantly decreased (P < 0.05, HolmSidak test) by pretreatment with 5 mM tetraethylammonium (n=5; Fig. 4A ). Significant reductions were also observed with 0.5 µM apamin The data are expressed as mean ± S.E.M. * P < 0.05, compared with respective control (one-way ANOVA followed by Holm-Sidak test).
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(n=6), 30 µM BaCl 2 (n=5), and 1 mM CsCl (n=5; Fig. 4B 
Discussion
In rat aorta, NPP exerted cGMP-dependent vasorelaxation (Brito 
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European Journal of Pharmacology 806 (2017 ) 52-58 et al., 2016 . In the present study, we confirmed the vasodilator properties of NPP using resistance arteries that were isolated from the rat mesenteric vascular bed. Vasorelaxant effects were observed in rings from second-and third-order branches of the mesenteric artery, tissues that are involved in the establishment of peripheral vascular resistance (Christensen and Mulvany, 2001; Mulvany and Aalkjaer, 1990) . When contractions were promoted in the rat aorta by stimulating α-adrenergic receptors with phenylephrine, the EC 50 value for relaxation was~30 µM (Brito et al., 2016) . In the present study, the corresponding EC 50 value was~0.4 µM (i.e.,~75-fold greater potency). Our findings also revealed the putative dependence of the relaxant effects of NPP on K + channels in mesenteric vessels, which is contrary to findings in rat aortic tissue (Brito et al., 2016) . Under Ca 2+ -free conditions, NPP did not inhibit caffeine-induced transient contractions even at a concentration (100 µM) that blocked the response that was induced by phenylephrine. In smooth muscle cells, caffeine induces Ca 2+ release via ryanodine receptors to induce contraction. This Ca 2+ release occurs from stores in sarcoplasmic reticulum that are distinct from those ones releasable by inositol triphosphate (IP 3 ), a product of G-protein coupled receptor-mediated phospholipase C activation (Lamont and Gil Wier, 2004; Vallot et al., 2001) . Such findings argue against the occurrence of nonspecific actions of NPP or putative detrimental effects on cell viability and suggest a preferential action of NPP on contractile mechanisms that are activated through G-protein-coupled receptors, which has previously been reported for phenylephrine and U-46619 (Crowley et al., 2002; Wilson et al., 2005) . A similar profile for another nitro compound with stimulatory effects on guanylate cyclase, 1-nitro-2-phenylethane, was previously reported (Brito et al., 2013) . Under Ca
2+
-free conditions, phenylephrine transiently contracts smooth muscle cells by recruiting Ca 2+ from internal stores via IP 3 receptor activation (Ehrlich and Watras, 1988) . Interestingly, 30 µM NPP significantly inhibited phenylephrine-induced contractions and decreased cytoplasmic Ca 2+ levels in preparations that were maintained in a Ca 2+ -containing medium, but 30 µM NPP did not influence the magnitude of transient contractions that were induced by phenylephrine in Ca 2+ -free medium. Therefore, we hypothesize that before NPP inhibits contractile responses that result from Ca 2+ release from intracellular stores in the sarcoplasmic reticulum, it inhibits the contribution of inward Ca 2+ currents that are triggered by the activation of Ca 2+ channels by G-protein coupled receptors (Crowley et al., 2002; Wilson et al., 2005) . The inhibitory effects of NPP occurred over a wide range of concentrations and were more potent against U-46610 than phenylephrine (EC 50 =0.16 and 0.41 µM, respectively). However, the closeness of these values suggests that a selective antagonism of NPP against TP receptors is implausible and reinforces the notion that NPP is not an adrenergic ligand (Crowley et al., 2002; Wilson et al., 2005) . Pharmacological potency decreased more manifestly when NPP relaxed contractions elicited by increasing concentrations of K + (40-120 mM;
EC 50 values increased from 4.50 to 41.91 µM), which offers pharmacological evidence for the involvement of K + channels and its hyperpolarizing properties in the vasodilator effects of NPP on mesenteric vessels. Smooth muscle contractions that are induced by high K + concentrations result from the depolarizing properties of K + on the cell membrane (Somlyo and Somlyo, 1968 et al., 2012) . This behavior was similar to NPP in the experimental protocol in which extracellular K + concentrations were increased from 40 to 120 mM. NPP at 10 µM fully relaxed contractions that were caused by phenylephrine and U-46619, and decreased relaxant responses were recorded in preparations that were subjected to higher extracellular K + concentrations.
We used various K + channel blockers to investigate the involvement of K + channels in the relaxant effects of NPP. Glibenclamide and 4-AP, blockers of ATP-activated and voltage-gated K + channels (Sobey, 2001 ), respectively, did not inhibit the effects of NPP. In contrast, the effects were reduced by tetraethylammonium and apamin, blockers of large-and small-conductance Ca
-activated K + channels, respectively (Langton et al., 1991; Murphy and Brayden, 1995) . Moreover, physiological solution that was enriched with BaCl 2 or CsCl, two nonselective blockers of inwardly rectifying K + channels (Nelson and Quayle, 1995; Quayle et al., 1993) , also reduced the vasorelaxant effects of NPP. In rat aorta, tetraethylammonium was inert against the inhibitory effects of NPP (Brito et al., 2016) . Thus, it is probable that the relaxant effects of NPP on mesenteric vessels involve recruitment of K + channels.
The importance of the endothelial layer to the vasorelaxant effects of NPP was investigated. In addition to nitric oxide and prostacyclin (PGI 2 ), the release of a putative EDHF plays a significant role in the microvasculature (Hilgers et al., 2006) . Thus, although the molecular identity of the EDHF remains controversial, its vasorelaxant effect appears to be related to the activation of small-and intermediateconductance Ca 2+ -activated K + channels (Tang et al., 2013; Bełtowski and Jamroz-Wiśniewska, 2014) . In the concomitant presence of L-NAME and indomethacin, the relaxant effect of acetylcholine in endothelium-intact preparations provides functional evidence of EDHF release (Andrews et al., 2009 ). The abolition of this acetylcholine-elicited relaxing response after the addition of apamin reinforces the notion that membrane hyperpolarization is involved in the smooth muscle relaxation under these experimental conditions (Triggle et al., 2012) . Nevertheless, NPP almost completely relaxed contractions that were induced by U-46619 in the presence of indomethacin and L-NAME. The addition of apamin only slightly reduced the inhibitory effect of NPP, in contrast to its more pronounced blunting effect on acetylcholine-elicited relaxation. These findings further support the hypothesis that the relaxation of mesenteric rings resulted from the likely hyperpolarizing influence of NPP, which does not appear to derive from EDHF release. The results of the experiments that used endothelium-denuded preparations provide additional clues that EDHF is not involved in the effects of NPP.
Endothelial vasoactive factors, such as nitric oxide and PGI 2 , relax vascular smooth muscle through a variety of mechanisms, including the hyperpolarization of membrane potential (Murphy and Brayden, 1995; Rubanyi et al., 1990) . The vasorelaxant effects of NPP do not appear to be attributable to the release of nitric oxide because it was unaffected by the presence of the nitric oxide synthase blocker L-NAME (Rees et al., 1990) . Prostaglandins also do not appear to be involved in the effects of NPP because they remained unaffected by indomethacin (Levine et al., 1972) .
The inhibition of pathways that are related to cyclic nucleotide synthesis blunted the vasorelaxant effects of NPP on mesenteric vessels. Cyclic nucleotides modulate vascular smooth muscle contractility by decreasing cytosolic Ca 2+ concentrations and the sensitivity of contractile machinery to cytosolic Ca 2+ (Akata, 2007; Morgado et al., 2012) . In the present study, the selective guanylate cyclase inhibitor ODQ (Garthwaite et al., 1995) , adenylyl cyclase inhibitor MDL-12,330A (Lippe and Ardizzone, 1991) , and protein kinase A inhibitor H-89 (Chijiwa et al., 1990) blunted NPP-induced vascular relaxation. In rat aorta, the vasodilator effects of NPP were weakly but significantly inhibited by MDL-12,330A (Brito et al., 2016) . However, further studies should confirm the ability of NPP to increase the levels of cyclic nucleotides in mesenteric tissues, such as the previous findings in aortic homogenates (Brito et al., 2016) .
The present study contains limitations and pharmacologic evidence in this approach does not allow a definite conclusion of how various cell pathways are linked to result in the relaxing effects of NPP.
Nevertheless, it is possible to conclude that NPP has potent vasorelaxant effects in rat mesenteric resistance vessels. They appear to involve the participation of cyclic nucleotides and the recruitment of K + channels, especially small-conductance Ca 2+ -activated potassium channels. Conjointly, such phenomena appear to reduce the intracellular levels of Ca 2+ to promote vasorelaxation. Such a dual profile, including the stimulation of cyclic nucleotide production and recruitment of K + channels, may be of pharmacological interest for cardiovascular disorders that involve, for example, angina pectoris (Taira, 1989) .
